XML 82 R68.htm IDEA: XBRL DOCUMENT v3.19.2
Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 03, 2019
Mar. 12, 2019
Feb. 08, 2019
May 06, 2016
Mar. 21, 2016
Mar. 21, 2016
Feb. 08, 2016
Dec. 29, 2015
Sep. 30, 2017
Jul. 24, 2017
May 26, 2017
Feb. 28, 2017
Oct. 02, 2016
Aug. 26, 2016
May 06, 2016
Mar. 31, 2016
Feb. 17, 2016
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Mar. 28, 2018
Aug. 31, 2017
Oct. 30, 2015
Equity (Textual)                                                
Common stock, authorized                                   20,000,000   20,000,000 360,000,000      
Common stock, par value                                   $ 0.001   $ 0.001 $ 0.001      
Description of forward split The Company filed a certificate of amendment to the Company's articles of incorporation (the "Amendment") to effect the Reverse Split with the Secretary of State of Nevada. The Financial Industry Regulatory Authority ("FINRA") informed the Company that the Reverse Split was effective on May 8, 2019. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse stock split. i) effect a stock reverse split at the ratio of 1-for-18 (the "Reverse Split") of both the authorized common stock of the Company (the "Common Stock") and the issued and outstanding Common Stock and ii) to amend the articles of incorporation of the Company to reflect the Reverse Split. The Board approved and authorized the Reverse Split without obtaining approval of the Company's shareholders pursuant to Section 78.207 of Nevada Revised Statutes.     1 to 3.141 1 to 3.141                                    
Subscription receivable                                               $ 350,000
Percentage of common shares issued and outstanding                                             73.00%  
Issuance of common shares                                   $ 694,219 $ 80,000 $ 80,000 $ 5,850,000      
Due to related parties                                   $ 7,594,784   $ 7,745,096 $ 4,229,320      
Common stock, shares issued                                   17,693,625   11,884,804 213,746,647      
Common stock, shares issued total                                           80,000    
Financial amendment, description                                   The Company filed a Certificate of Amendment with the Secretary of State of Nevada, which was effective May 8, 2019 upon its receipt of the written notice from Financial Industry Regulatory Authority ("FINRA"). Pursuant to the Certificate of Amendment, the Company effectuated a 1-for-18 reverse stock split of its issued and outstanding shares of common stock, $0.001 par value, whereby 318,485,252 outstanding shares of the Company's common stock were exchanged for 17,693,625 shares of the Company's Common Stock. All shares and related financial information in this Form 10-Q reflect this 1-for-18 reverse stock split.            
Agreement, description                       The Company remitted this amount to BioLite with $650,000 in cash and $5,850,000 in the form of newly issued shares of the Company's Common Stock, at the price of $2.0 per share, for an aggregate number of 2,925,000 shares. Upon the consummation of the restructuring transaction between the Company and BioLite on February 8, 2019, the Company's Common Stock held by BioLite Taiwan was accounted for treasury stocks in the statement of equity (deficit).   The Company issued 1,468,750 shares ("Shares") of the Company's Common Stock, par value $0.001 (the "Offering") to BioLite Taiwan pursuant to a certain Stock Purchase Agreement dated August 26, 2016 (the "SPA"). The Shares are exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Regulation S of the Securities Act promulgated thereunder. The purchase price per share of the Offering is $1.60. The net proceeds to the Company from the Offering are approximately $2,350,000. Pursuant to the BioLite Collaborative Agreement, BriVision should pay a total of $100,000,000 in cash or stock of the Company with equivalent value according to the milestone achieved. The agreement requires that 6.5% of total payment, $6,500,000 shall be made upon the first IND submission which was submitted in March 2016. The Company and BioLite Taiwan agreed to amend the BioLite Collaborative Agreement, through entry into the Milestone Payment Agreement, whereby the Company has agreed to issue shares of Common Stock of the Company, at the price of $1.60 per share, for an aggregate number of 562,500 shares, as part of the Company's first installation of payment pursuant to the Milestone Payment. The shares issuance was completed in June 2016.                  
BioLite, Inc., [Member]                                                
Equity (Textual)                                                
Common stock, par value                           $ 0.001                    
Issuance of common shares                           $ 1,468,750                    
Purchase price per share                           $ 1.60                    
Net proceeds from offering                           $ 2,350,000                    
Kimho Consultants Co., Ltd [Member]                                                
Equity (Textual)                                                
Common stock, par value                                           $ 1.60    
Common stock, shares issued                                           75,000    
Common stock, shares issued total                                           120,000    
2016 Equity Incentive Plan [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split                                 50,000              
Common stock issued post-stock split                                 157,050              
Collaborative Arrangement [Member]                                                
Equity (Textual)                                                
Issuance of common shares       $ 900,000           $ 3,000,000                            
Issuance of common shares, shares       562,500                                        
Share price       $ 1.60               $ 2.0     $ 1.60                  
Due to related parties                                   $ 100,000,000   $ 100,000,000        
Total payment upon first IND submission                                   $ 15,000,000   $ 15,000,000        
Percentage of payments under collaborative agreement               3.50%   50.00%               15.00%   15.00%        
Consulting agreement, description                         The Company agreed to indemnify the consultant in an amount of $150 per hour in cash up to $3,000 per month, and issue to Kameyama the Company's Common Stock at $1.00 per share for any amount exceeding $3,000.                      
Share Exchange Agreement [Member]                                                
Equity (Textual)                                                
Description of forward split             ABVC issued an aggregate of 104,558,777 shares (prior to the reverse stock split in 2019) to the shareholders of both BioLite and BioKey under a registration statement on Form S-4 (file number 333-226285), which became effective by operation of law on or about February 5, 2019.                                  
Common stock issued pre-stock split             52,336,000                                  
Common stock issued post-stock split             164,387,376                                  
Share Exchange Agreement One [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             52,936,583                                  
Common stock issued post-stock split             166,273,921                                  
Share Exchange Agreement Two [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             51,945,225                                  
Common stock issued post-stock split             163,159,952                                  
Percentage of common shares issued and outstanding             79.70%                                  
Percentage of issued share capital             100.00%                                  
Share Exchange Agreement Three [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             52,936,583                                  
Common stock issued post-stock split             166,273,921                                  
Exchange ratio             0.2536-for-1                                  
Share Exchange Agreement Four [Member]                                                
Equity (Textual)                                                
Common stock issued pre-stock split             65,431,144                                  
Common stock issued post-stock split             205,519,223                                  
Percentage of common shares issued and outstanding             79.70%                                  
Co-Dev Agreement [Member]                                                
Equity (Textual)                                                
Company cash payments                 $ 3,000,000   $ 3,000,000                          
Due to related parties                     $ 3,000,000                          
Total payment upon first IND submission                                       $ 15,000,000        
Percentage of payments under collaborative agreement                     50.00%                          
Collaborative Arrangement One [Member]                                                
Equity (Textual)                                                
Issuance of common shares                       $ 5,850,000                        
Issuance of common shares, shares                       2,925,000                        
Share price                       $ 2.0                        
Due to related parties                           $ 100,000,000                    
Total payment upon first IND submission                               $ 6,500,000                
Percentage of payments under collaborative agreement                               6.50%                
Euro-Asia Investment & Finance Corp Ltd. [Member]                                                
Equity (Textual)                                                
Common stock, par value                                           $ 1.60    
Common stock, shares issued                                           50,000    
Common stock, shares issued total                                           80,000    
Consulting Agreement [Member]                                                
Equity (Textual)                                                
Common stock, par value                                           $ 1.60    
Stock based compensation expenses                                   $ 28,800 5,400 28,800 $ 5,400      
Common stock, shares issued                                           4,828    
Common stock, shares issued total                                           7,725    
Euro-Asia Agreement [Member]                                                
Equity (Textual)                                                
Stock based compensation expenses                                   0 60,000 0 60,000      
Kimho Agreement [Member]                                                
Equity (Textual)                                                
Stock based compensation expenses                                   $ 0 $ 90,000 $ 0 $ 90,000      
BioKey [Member]                                                
Equity (Textual)                                                
Issuance of common shares, shares     29,561,231                                          
Share price     $ 1.50                                          
BioLite [Member]                                                
Equity (Textual)                                                
Issuance of common shares, shares     74,997,546